Aurgalys Team
Selected Customers
Home
Interim Management
Quantum Genomics [ALQGC]
Corporate Finance
Management Assistance
Due Diligence
Interim Management
Investor Assistance
Onxeo [ONXEO]
Diaxonhit [ALEHT]
 

March 25th, 2015: Aurgalys releases new analyst reports on Onxeo [Euronext:ONXEO]

mars 25, 2015

Paris-Evry, France, March 25th, 2015 – Aurgalys, a global provider for life sciences and healthcare companies through corporate finance, business development and interim management services, issued new analyst report on Onxeo.

« Onxeo’s 2014 annual results confirmed the successful integration of Danish Topotarget and the relevance of this strategic acquisition in the field of orphan oncology. The merger allowed the company to generate more than €35M in revenue for 2014 (pro forma), and a net profit of €7.3M if non-recurring expenses are excluded. […] »

You can download our report (in English) at the following link:

Comments are closed.